Emerging Infections 10 / Edition 1

by W. Michael Scheld, James M. Hughes, Richard J. Whitley

Overview

Essential resource for the fight against emerging infectious diseases

Incidences such as the 2014 Ebola epidemic in West Africa and the 2015 appearance of Zika in Brazil provide dramatic evidence of the continued ability of microbes to emerge, spread, adapt, and threaten global health. The challenge facing infectious disease specialists and public health professionals is to improve and find new diagnostic, therapeutic, and prevention strategies.

The editors of the 10th installment of the Emerging Infections series have compiled the perspectives of leading infectious disease experts into 22 chapters that provide important updates on a broad range of emerging and reemerging bacterial, viral, parasitic, and fungal infectious diseases in the United States and globally. In addition to focusing on MERS, Ebola virus disease, chikungunya, and Zika virus disease, Emerging Infections 10 explores the global threat of antimicrobial resistance in reviews on carbapenem-resistant Enterobacteriaceae, multiply-resistant gonococcal infections, non-typhoidal Salmonella infections, and artemisinin-resistant Plasmodium falciparum malaria. Topics include both recently- and long-recognized diseases that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

Emerging Infections 10 presents new and emerging strategies to prevent, control, and eradicate infectious diseases and guides readers to the primary literature where they can explore individual topics in greater depth. This book is a valuable reference for professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

Product Details

ISBN-13:	9781555819446
Publisher:	Wiley
Publication date:	06/21/2016
Series:	ASM Books , #10
Pages:	464
Sales rank:	1,053,759
Product dimensions:	7.10(w) x 10.00(h) x 1.10(d)

About the Author

W. Michael Scheld, MD, is the Bayer-Gerald Mandell Professor of Infectious Diseases, Professor of Medicine, Clinical Professor of Neurosurgery, and Director of the Center for Global Health at the University of Virginia School of Medicine. Dr. Scheld’s research includes the molecular pathogenesis and pathophysiology of bacterial infections, anti-inflammatory mechanisms of adenosine receptor subtype agonists and antagonists, antimicrobial resistance, sepsis and septic shock, anthrax, and international health issues including HIV/AIDS in Africa.

James M. Hughes, MD, is Professor of Medicine and Public Health with joint appointments in the School of Medicine (Infectious Diseases) and the Rollins School of Public Health (Global Health) at Emory University and Co-Director of the Emory Antibiotic Resistance Center. Dr. Hughes’ research includes emerging and reemerging infectious diseases; antimicrobial resistance; healthcare-associated infections; vectorborne and zoonotic diseases; foodborne and waterborne diseases; vaccine-preventable diseases; rapid detection of and response to infectious diseases and bioterrorism; and strategies for strengthening public health capacity at the local, national, and global levels.

Table of Contents

Contributors ix

Foreword xv

Preface xvii

Acknowledgments xix

1 West Africa 2013: Re-examining Ebola Daniel G. Bausch Amanda Rojek 1

2 Preparing for Serious Communicable Diseases in the United States: What the Ebola Virus Epidemic Has Taught Us Jay B. Varkey Bruce S. Ribner 39

3 Ebola Virus Disease: Therapeutic and Potential Preventative Opportunities Robert Fisher Luciana Borio 53

4 Middle East Respiratory Syndrome (MERS) Sonja A. Rasmussen Amelia K. Watson David L. Swerdlow 73

5 The Emergence of Enterovirus D-68 Kevin Messacar Mark J. Abzug Samuel R. Domingaez 104

6 The Role of Punctuated Evolution in the Pathogenicity of Influenza Viruses Jonathan A. McCullers 121

7 Measles in the United States since the Millennium: Perils and Progress in the Postelimination Era Anne Schuchat Amy Parker Fiebelkorn William Bellini 131

8 Chikungunya Virus: Current Perspectives on a Re emerging Virus Clayton R. Morrison Kenneth S. Plante Mark T. Heise 143

9 Zika Virus Disease Werner Slenczka 163

10 West Nile Virus Infection James J. Sejvar 175

11 Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae Amy Mathers 201

12 Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century Magnus Unemo Carlos del Rio William M. Shafer 213

13 Bordetella holmesii: Still Emerging and Elusive 20 Years On Laure F. Pittet Klara M. Posfay-Barbe 239

14 Cronobacter spp. Brian P. Blackwood Catherine J. Hunter 255

15 Clostridium difficile Infection Jae Hyun Shin Esteban Chaves-Olarte Cirle A. Warren 265

16 Emerging Tick-Borne Bacterial Pathogens Tahar Kernif Hamza Leulmi Didier Raoult Philippe Parola 295

17 Bordetella pertussis Delma J. Nieves Ulrich Heininger 311

18 Invasive Infections with Nontyphoidal Salmonella in Sub-Saharan Africa Barbara E. Mahon Patricia I. Fields 341

19 Fungal Infections Associated with Contaminated Steroid Injections Carol A. Kauffinan Anurag N. Malani 359

20 Emerging Fungal Infections in the Pacific Northwest: The Unrecognized Burden and Geographic Range of Cryptococcus gattii and Coccidioides immitis Shawn R. Lockhart Orion Z. McCotter Tom M. Chiller 375

21 The Emerging Amphibian Fungal Disease, Chytridiomycosis: A Key Example of the Global Phenomenon of Wildlife Emerging Infectious Diseases Jonathan E. Kolby Peter Daszak 385

22 Artemisinin-Resistant Plasmodium falciparum Malaria Rick M. Fairhurst Arjen M. Dondorp 409

Index 431

Editorial Reviews

Reviewer: Mark E. Rupp, MD (University of Nebraska Medical Center )
Description: The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.
Purpose: The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.
Audience: Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.
Features: The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection, but does not address other clinical issues.
Assessment: Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.

Doody's Review Service

Description

The 10th volume of this series, which originated in 1998, remains highly pertinent and informative as emerging and re-emerging infectious diseases become ever more important. Written by 49 well-qualified authors (including over a dozen from outside the U.S.) from major academic institutions as well as the CDC, FDA, NIH, and WHO, the 22 chapters examine emerging pathogens MERS, Enterovirus D68, Chikungunya, Zika, carbapenem-resistant Enterobacteriaceae (CRE), antibiotic-resistant gonorrhea, etc. Three chapters are dedicated to Ebola due to its recent impact and general interest.

Purpose

The three well-known editors seek to update readers on a wide-ranging list of prominent emerging viral, bacterial, and fungal pathogens as well as a few less well-known or more esoteric pathogens such as B. holmesii, Cronobacter spp., tick-borne bacterial pathogens, and amphibian fungal diseases. In addition, several chapters deal with more mechanistic concerns such as punctuated evolution in the pathogenicity of influenza, fungal contamination of steroid injections, and challenges in preventing the re-emergence of measles.

Audience

Students, teachers, clinicians, laboratorians, and investigators in the disciplines of microbiology, infectious diseases, and public health will find value in the concise, well-written, and adequately referenced chapters.

Features

The foreword and preface do a nice job of setting the scene. The first three chapters on Ebola are organized into West African experience, lessons from Ebola in preparing for serious communicable diseases in the United States, and Ebola therapeutics. Although each chapter is excellent on its own, there is substantial redundancy when read together. To better hold the reader's attention, the authors of almost all of the chapters (exceptions are non-typhoidal salmonella and Zika) offer appropriate graphics, charts, and tables. The chapters on MERS, measles, Enterovirus D68, and C. difficile are concise yet comprehensive reviews. The scope of the chapter on CRE concentrates on epidemiology and laboratory detection but does not address other clinical issues.

Assessment

Global forces such as population growth, climate change, world travel, and trade will continue to influence the emergence and transmission of infectious diseases. This volume nicely summarizes information on a variety of pathogens and serves as a great reminder of the importance of preparedness and public health on a national and global scale.

Weighted Numerical Score: 90 - 4 Stars!

-DOODY'S REVIEW SERVICE (NO INDIVIDUAL REVIEWER NOTED)

From the Publisher